Thalamic disequilibrium syndrome after thrombolytic therapy for acute myocardial infarction.
Nandhagopal
R
R
Department of Neurology, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India. rnandagopal@yahoo.com
Vengamma
B
B
Krishnamoorthy
S G
SG
Rajasekhar
D
D
Subramanyam
G
G
D000368:Aged; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D020233:Gait Disorders, Neurologic / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D004856:Postural Balance / Q000187:drug effects / Q000502:physiology; D013300:Streptokinase / Q000009:adverse effects; D013786:Thalamic Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D013788:Thalamus / Q000098:blood supply / Q000473:pathology* / Q000503:physiopathology
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D013300:Streptokinase